Condition: Intermediate AMD · Sponsor: OD-OS MacuTherm GmbH
The goal of this study is to demonstrate that photothermal therapy with the individually dosed treatment plan proposed by Macula Explorer delivered safely by Navilas® Laser System effectively improves the life of photoreceptors and reduces the progression of intermediate Age-related Macular Degeneration (iAMD) and preserves photoreceptors shown by Ellipsoid Zone Integrity (EZI). Participants will be randomized to either Treatment or Control Group. There will be 12 visits, monthly for the first 3 months, then quarterly until the end of the study after 2 years.
This description comes directly from the study's public registry record.
Jan Tode, Prof. Dr. med. · +49 3328 31 282-100 · Jan.Tode@od-os.com
Always discuss trial participation with your own doctor first.
| Department of Ophthalmology at Hannover Medical School | Hanover, Germany | Not Yet Recruiting |
| Department of Ophthalmology, University Medical Center Schleswig-Holstein | Lübeck, Germany | Not Yet Recruiting |
| Potsdam Eye Clinic at Gräfehaus | Potsdam, Germany | Recruiting |
| AugenNord Medical Practice and Surgical Center | Schleswig, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07607496